tofacitinib citrate
SpainDrugs containing this active substance
-
It is used to treat active polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis in patients 2 years of age or older. It may be taken alone or in combination with methotrexate.
Form: solution, oral
Active substance Dosage tofacitinib citrate 1,62 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat various inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and juvenile idiopathic arthritis (both polyarticular and psoriatic).
Form: tablets, film-coated
Active substance Dosage tofacitinib citrate 16,155 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat inflammatory diseases such as rheumatoid arthritis (in adults with moderate to severe cases), psoriatic arthritis, and ankylosing spondylitis (inflammation of the spine).
Form: tablets, prolonged-release
Active substance Dosage tofacitinib citrate 17,77 mg Manufacturer: Pfizer Europe Ma Eeig
-
It is used to treat inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, and juvenile psoriatic arthritis.
Form: tablets, film-coated
Active substance Dosage tofacitinib citrate 8,078 mg Manufacturer: Pfizer Europe Ma Eeig